| Prescription sales, which made up nearly two 
				thirds of the company's total sales, rose 9.3 percent in the 
				fourth quarter ended Aug. 31.
 Total revenue rose to $19.06 billion in the quarter from $17.94 
				billion a year earlier.
 
 The net loss attributable to the company was $239 million, or 25 
				cents per share, in the quarter, and included an $866 million 
				non-cash loss due to the amendment and exercise of its Alliance 
				Boots call option.
 
 Walgreen posted a profit of $657 million, or 69 cents per share, 
				a year earlier.
 
 Excluding items, the company earned 74 cents per share in the 
				latest quarter.
 
 The company's shares rose 3.2 percent to $61.50 in trading 
				before the bell on Tuesday.
 
 (Reporting by Nandita Bose in Chicago and Sruthi Ramakrishnan in 
				Bangalore; Editing by Savio D'Souza)
 
			[© 2014 Thomson Reuters. All rights 
				reserved.] Copyright 2014 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed. 
				 |  |